Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Lipoprotein(a)—the crossroads of atherosclerosis, atherothrombosis and inflammation
ID
Ugovšek, Sabina
(
Author
),
ID
Šebeštjen, Miran
(
Author
)
PDF - Presentation file,
Download
(1,86 MB)
MD5: 007DD2B2772B1C0E46003B1E1F7B880D
URL - Source URL, Visit
https://www.mdpi.com/2218-273X/12/1/26
Image galllery
Abstract
Increased lipoprotein(a) (Lp(a)) levels are an independent predictor of coronary artery disease (CAD), degenerative aortic stenosis (DAS), and heart failure independent of CAD and DAS. Lp(a) levels are genetically determinated in an autosomal dominant mode, with great intra- and inter-ethnic diversity. Most variations in Lp(a) levels arise from genetic variations of the gene that encodes the apolipoprotein(a) component of Lp(a), the LPA gene. LPA is located on the long arm of chromosome 6, within region 6q2.6–2.7. Lp(a) levels increase cardiovascular risk through several unrelated mechanisms. Lp(a) quantitatively carries all of the atherogenic risk of low-density lipoprotein cholesterol, although it is even more prone to oxidation and penetration through endothelia to promote the production of foam cells. The thrombogenic properties of Lp(a) result from the homology between apolipoprotein(a) and plasminogen, which compete for the same binding sites on endothelial cells to inhibit fibrinolysis and promote intravascular thrombosis. LPA has up to 70% homology with the human plasminogen gene. Oxidized phospholipids promote differentiation of pro-inflammatory macrophages that secrete pro-inflammatory cytokines (e. g., interleukin (IL)-1β, IL-6, IL-8, tumor necrosis factor-α). The aim of this review is to define which of these mechanisms of Lp(a) is predominant in different groups of patients.
Language:
English
Keywords:
lipoprotein(a)
,
atherothrombosis
,
inflammation
,
coagulation
,
fibrinolysis
Work type:
Article
Typology:
1.02 - Review Article
Organization:
MF - Faculty of Medicine
Publication status:
Published
Publication version:
Version of Record
Year:
2022
Number of pages:
14 str.
Numbering:
Vol. 12, iss. 1, art. 26
PID:
20.500.12556/RUL-136812
UDC:
612.115+616.13-004.6
ISSN on article:
2218-273X
DOI:
10.3390/biom12010026
COBISS.SI-ID:
91854339
Publication date in RUL:
23.05.2022
Views:
608
Downloads:
115
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Biomolecules
Shortened title:
Biomolecules
Publisher:
MDPI
ISSN:
2218-273X
COBISS.SI-ID:
519952921
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
01.01.2022
Secondary language
Language:
Slovenian
Keywords:
lipoprotein(a)
,
aterotromboza
,
koagulacija
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back